PDL BIOPHARMA

PDL BioPharma (known as Protein Design Labs prior to 2006) is a publicly traded American shell company that since 2008 manages patents and other intellectual property that had been generated by the company. In 2008 in response to shareholder pressure, PDL spun out its active development programs to a company called Facet Biotech that it capitalized with $400 million. Wikipedia

PDL BioPharma (known as Protein Design Labs prior to 2006) is a publicly traded American shell company that since 2008 manages patents and other intellectual property that had been generated by the company. In 2008 in response to shareholder pressure, PDL spun out its active development programs to a company called Facet Biotech that it capitalized with $400 million. Wikipedia